Detalhe da pesquisa
1.
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
Cancer
; 126(17): 3972-3981, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32557577
2.
A Comparison of Three-Layer and Single-Layer Small Vascular Grafts Manufactured via the Roto-Evaporation Method.
Polymers (Basel)
; 16(10)2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38794507
3.
Novel copper complexes-polyurethane composites that mimics anti-inflammatory response.
J Biomater Sci Polym Ed
; 34(8): 1067-1089, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36475413
4.
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study.
Lancet Oncol
; 11(2): 129-35, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20036194
5.
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.
J Clin Oncol
; 39(17): 1856-1864, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750196
6.
Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers.
Blood Adv
; 5(24): 5588-5598, 2021 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592752
7.
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms.
Leukemia
; 35(12): 3542-3550, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172893
8.
A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations.
Clin Cancer Res
; 26(19): 5113-5119, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32636318
9.
Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas.
Mol Cancer Ther
; 19(9): 1784-1796, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727882
10.
Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma.
Sci Rep
; 10(1): 6721, 2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317694
11.
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma.
J Transl Med
; 6: 22, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18452610
12.
Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors.
Clin Cancer Res
; 13(19): 5834-40, 2007 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17908976
13.
Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor.
Clin Cancer Res
; 13(12): 3611-6, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17575225
14.
Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays.
Clin Cancer Res
; 12(1): 107-16, 2006 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16397031
15.
Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.
Clin Cancer Res
; 11(5): 2063-73, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15756033
16.
Vascular smooth muscle polyploidization--from mitotic checkpoints to hypertension.
Cell Cycle
; 2(2): 105-10, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12695657
17.
Loss of mitotic spindle checkpoint activity predisposes to chromosomal instability at early stages of fibrosarcoma development.
Cell Cycle
; 2(3): 238-45, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12734433
18.
Brentuximab Vedotin (SGN-35), an antibody-drug conjugate for the treatment of CD30-positive malignancies.
Expert Opin Investig Drugs
; 21(2): 205-16, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22127011
19.
Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma.
J Clin Oncol
; 29(34): 4534-40, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22025154
20.
Figitumumab (CP-751,871) for cancer therapy.
Expert Opin Biol Ther
; 10(4): 575-85, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20175655